Cargando…
The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial
BACKGROUND: Patients with haematological malignancies often develop thrombocytopenia as a consequence of either their disease or its treatment. Platelet transfusions are commonly given to raise a low platelet count and reduce the risk of clinical bleeding (prophylaxis) or stop active bleeding (thera...
Autores principales: | Estcourt, Lise J., McQuilten, Zoe, Powter, Gillian, Dyer, Claire, Curnow, Eleanor, Wood, Erica M., Stanworth, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792262/ https://www.ncbi.nlm.nih.gov/pubmed/31615553 http://dx.doi.org/10.1186/s13063-019-3663-2 |
Ejemplares similares
-
Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia
por: Ilich, Anton, et al.
Publicado: (2022) -
Use of tranexamic acid in dogs with primary immune thrombocytopenia: A feasibility study
por: Olivares, Gerard, et al.
Publicado: (2023) -
HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial
por: Roberts, Ian, et al.
Publicado: (2014) -
Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split‐face comparative trial
por: Pazyar, Nader, et al.
Publicado: (2022) -
Applying results from clinical trials: tranexamic acid in trauma patients
por: Roberts, Ian, et al.
Publicado: (2014)